| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |